RASHMI KRISHNA MURTHY to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
0.025
-
Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC). Clin Cancer Res. 2017 Jul 15; 23(14):3529-3536.
Score: 0.025